ArticleBMC neurology2026
Multiple sclerosis knowledge among primary care physicians practicing in primary health centers in Bahrain: a cross-sectional study.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Kingdom of Bahrain is recognized as one of the countries with a high risk of multiple sclerosis (MS). As the initial point of contact for healthcare services in the Bahraini system, primary care physicians (PCPs) are not uncommonly confronted with MS patients in their practices. This study aimed to identify common knowledge gaps among PCPs in Bahrain across various aspects of MS to shorten diagnostic lag and enable smooth & comprehensive care flow for MS patients.
methodsThis cross-sectional study took place between October and December 2023. All PCPs practicing in 27 health centers in Bahrain (n = 428) were invited to complete a self-administered questionnaire assessing their socio-demographics, expertise, and background knowledge of MS pathophysiology, clinical diagnosis, investigations, and treatment.
resultsOnly 211 completed the questionnaire (response rate = 49.3%). Most respondents retained adequate information about MS being an immune-mediated disorder (58.3%) of the central nervous system (58.3%), with higher occurrence among females (67.3%) in the 20-40 s age group (89%), with the relapsing-remitting being the most common type (60.2%) & MRI being the preferred initial diagnostic investigation in suspected cases (75.8%). Only 50.7% of respondants identified the time based criteria required for defining an MS relapse; however, 41.2% accredited Methylprednisolone 500-1000 mg as the main treatment of an MS relapse. Among those who reported knowledge of current disease-modifying therapies (n = 102), interferon β was the most frequently reported (66; 64.7%).
conclusionsPCPs practicing in Bahrain have acceptable knowledge about MS demographics, causes, types, and symptoms, with shortcomings regarding the diagnosis and treatment. This should promote collaboration between PCPs and MS specialists and facilitate tailored educational workshops/seminars centred on the different aspects of MS care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.